The stock of ON Semiconductor Corp (NASDAQ:ON) is a huge mover today! About 1.17M shares traded hands. ON Semiconductor Corp (NASDAQ:ON) has risen 39.43% since March 8, 2016 and is uptrending. It has outperformed by 30.11% the S&P500.
The move comes after 6 months positive chart setup for the $4.88 billion company. It was reported on Oct, 11 by Barchart.com. We have $19.75 PT which if reached, will make NASDAQ:ON worth $3.22B more.
ON Semiconductor Corp (NASDAQ:ON) Ratings Coverage
Out of 15 analysts covering ON Semiconductor Corp. (NASDAQ:ON), 10 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 67% are positive. ON Semiconductor Corp. has been the topic of 21 analyst reports since August 4, 2015 according to StockzIntelligence Inc. The rating was initiated by CLSA on Wednesday, May 25 with “Outperform”. The firm has “Buy” rating given on Tuesday, September 20 by Stifel Nicolaus. Longbow upgraded ON Semiconductor Corp (NASDAQ:ON) on Wednesday, August 24 to “Buy” rating. As per Thursday, June 2, the company rating was initiated by Stephens. TheStreet downgraded the stock to “Hold” rating in Monday, August 17 report. On Thursday, January 7 the stock rating was maintained by Wedbush with “Outperform”. Needham maintained the stock with “Buy” rating in Monday, November 2 report. The firm has “Buy” rating given on Thursday, November 19 by Citigroup. The firm has “Neutral” rating by Wedbush given on Tuesday, August 4. The stock has “Equal-Weight” rating given by Morgan Stanley on Thursday, September 22.
According to Zacks Investment Research, “Oncobiologics, Inc. is a clinical-stage biopharmaceutical company which engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology. Its product pipeline consists of ONS-3010, ONS-1045, ONS-1050, ONS-1055, ONS-4010, ONS-3030, ONS-3035 and ONS-3040 which are in preclinical stage. The company employs its BioSymphony(TM) Platform to address the challenges of biosimilar development and commercialization by developing mAb biosimilars. Oncobiologics, Inc. is headquartered in Cranbury, New Jersey.”
Another recent and important ON Semiconductor Corp (NASDAQ:ON) news was published by Profitconfidential.com which published an article titled: “ON Semiconductor Corp: If ON Stock Does This, it Will Explode” on September 27, 2016.
ON Company Profile
ON Semiconductor Corporation, incorporated on June 22, 2000, offers a portfolio of analog, digital and mixed signal integrated circuits (ICs), standard products, image sensors and custom devices for clients to solve their design challenges in advanced electronic systems and products. The Firm operates through four divisions: Application Products Group, Image Sensor Group, Standard Products Group, and System Solutions Group. The Company’s power management and motor driver semiconductor components control, convert, protect and monitor the supply of power to the different elements within a range of electronic devices. The Company’s custom application specific integrated circuits (ASICs) use analog, digital signal processing (DSP), mixed-signal and advanced logic capabilities for its automotive, medical, military/aerospace, consumer and industrial customers’ products. The Company’s signal management semiconductor components provide clock management and data flow management for precision computing, communications and industrial systems. The Company’s image sensors, optical image stabilization and auto focus devices provide advanced imaging solutions for automotive, wireless, industrial and consumer applications.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.